These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 10782886)

  • 1. Feasibility of simultaneous fluorescence immunophenotyping and fluorescence in situ hybridization study for the detection of estrogen receptor expression and deletions of the estrogen receptor gene in breast carcinoma cell lines.
    Zhang Y; Siebert R; Matthiesen P; Harder S; Theile M; Scherneck S; Schlegelberger B
    Virchows Arch; 2000 Mar; 436(3):271-5. PubMed ID: 10782886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Invasive ductal carcinoma of the breast: study of the number of copies of the CCND1 gene and chromosome 11 using fluorescence in situ hybridization (FISH) in comparison with expression of cyclin D1 protein and estrogen receptors (ER alpha) with immunohistochemical detection].
    Mrhalová M; Kodet R; Strnad P
    Cas Lek Cesk; 2002 Nov; 141(22):708-14. PubMed ID: 12532908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of 6q deletions in breast carcinoma cell lines by fluorescence in situ hybridization.
    Zhang Y; Matthiesen P; Siebert R; Harder S; Theile M; Scherneck S; Schlegelberger B
    Hum Genet; 1998 Dec; 103(6):727-9. PubMed ID: 9921911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of CDKN2 deletions in tumor cell lines and primary glioma by interphase fluorescence in situ hybridization.
    Dreyling MH; Bohlander SK; Adeyanju MO; Olopade OI
    Cancer Res; 1995 Mar; 55(5):984-8. PubMed ID: 7867008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Delineation of 6q deletions in breast carcinoma cell lines by fluorescence in situ hybridization].
    Zhang Y; Zhou J; Weng L; Gu W
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Feb; 17(1):20-3. PubMed ID: 10653903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns.
    Gruvberger S; Ringnér M; Chen Y; Panavally S; Saal LH; Borg A ; Fernö M; Peterson C; Meltzer PS
    Cancer Res; 2001 Aug; 61(16):5979-84. PubMed ID: 11507038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of human estrogen receptor using an efficient adenoviral gene delivery system is able to restore hormone-dependent features to estrogen receptor-negative breast carcinoma cells.
    Lazennec G; Katzenellenbogen BS
    Mol Cell Endocrinol; 1999 Mar; 149(1-2):93-105. PubMed ID: 10375022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen receptor gene analysis in estrogen receptor-positive and receptor-negative primary breast cancer.
    Roodi N; Bailey LR; Kao WY; Verrier CS; Yee CJ; Dupont WD; Parl FF
    J Natl Cancer Inst; 1995 Mar; 87(6):446-51. PubMed ID: 7861463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and regulation of estrogen receptor beta in human breast tumors and cell lines.
    Vladusic EA; Hornby AE; Guerra-Vladusic FK; Lakins J; Lupu R
    Oncol Rep; 2000; 7(1):157-67. PubMed ID: 10601611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FISH and FICTION in Lymphoma Research.
    Giefing M; Siebert R
    Methods Mol Biol; 2019; 1956():249-267. PubMed ID: 30779038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer.
    Konecny G; Pauletti G; Pegram M; Untch M; Dandekar S; Aguilar Z; Wilson C; Rong HM; Bauerfeind I; Felber M; Wang HJ; Beryt M; Seshadri R; Hepp H; Slamon DJ
    J Natl Cancer Inst; 2003 Jan; 95(2):142-53. PubMed ID: 12529347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are ER+PR+ and ER+PR- breast tumors genetically different? A CGH array study.
    Carracedo A; Salido M; Corominas JM; Rojo F; Ferreira BI; Suela J; Tusquets I; Corzo C; Segura M; Espinet B; Cigudosa JC; Arumi M; Albanell J; Serrano S; Solé F
    Cancer Genet; 2012 Apr; 205(4):138-46. PubMed ID: 22559974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of 9p deletions in leukemia cell lines by interphase fluorescence in situ hybridization with YAC-derived probes.
    Dreyling MH; Kobayashi H; Olopade OI; Le Beau MM; Rowley JD; Bohlander SK
    Cancer Genet Cytogenet; 1995 Aug; 83(1):46-55. PubMed ID: 7656204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of twenty alternatively spliced estrogen receptor alpha mRNAs in breast cancer cell lines and tumors using splice targeted primer approach.
    Poola I; Koduri S; Chatra S; Clarke R
    J Steroid Biochem Mol Biol; 2000 Apr; 72(5):249-58. PubMed ID: 10822014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance of human breast-cancer cells to the pure steroidal anti-estrogen ICI 182,780 is not associated with a general loss of estrogen-receptor expression or lack of estrogen responsiveness.
    Larsen SS; Madsen MW; Jensen BL; Lykkesfeldt AE
    Int J Cancer; 1997 Sep; 72(6):1129-36. PubMed ID: 9378550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of estrogen receptor beta isoforms in human breast cancer tissues and cell lines.
    Tong D; Schuster E; Seifert M; Czerwenka K; Leodolte S; Zeillinger R
    Breast Cancer Res Treat; 2002 Feb; 71(3):249-55. PubMed ID: 12002343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a gene (GPR30) with homology to the G-protein-coupled receptor superfamily associated with estrogen receptor expression in breast cancer.
    Carmeci C; Thompson DA; Ring HZ; Francke U; Weigel RJ
    Genomics; 1997 Nov; 45(3):607-17. PubMed ID: 9367686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypermethylation pattern of ESR and PgR genes and lacking estrogen and progesterone receptors in human breast cancer tumors: ER/PR subtypes.
    Pirouzpanah S; Taleban FA; Mehdipour P; Sabour S; Atri M
    Cancer Biomark; 2018 Feb; 21(3):621-638. PubMed ID: 29278880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two promoters in expression of estrogen receptor messenger RNA in human breast cancer.
    Hayashi S; Imai K; Suga K; Kurihara T; Higashi Y; Nakachi K
    Carcinogenesis; 1997 Mar; 18(3):459-64. PubMed ID: 9067542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moesin expression is associated with the estrogen receptor-negative breast cancer phenotype.
    Carmeci C; Thompson DA; Kuang WW; Lightdale N; Furthmayr H; Weigel RJ
    Surgery; 1998 Aug; 124(2):211-7. PubMed ID: 9706140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.